Laurion Capital Management LP Spruce Biosciences, Inc. Transaction History

Laurion Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.85 - $4.59 $20,973 - $52,036	-11,337 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.01 - $11.26 $21,756 - $40,761	-3,620 Reduced 24.2%	11,337 $68,000
Q2 2021 Aug 13, 2021	SELL	$10.12 - $17.46 $51,035 - $88,050	-5,043 Reduced 25.22%	14,957 $168,000
Q4 2020 Feb 12, 2021	BUY	$15.38 - $32.42 $307,600 - $648,400	20,000 New	20,000 $486,000

15.4M

16.7K

1.1K

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $9.42M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.